Pages that link to "Q35159258"
Jump to navigation
Jump to search
The following pages link to Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial (Q35159258):
Displaying 50 items.
- An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A (Q22000603) (← links)
- Ascorbic acid for the treatment of Charcot-Marie-Tooth disease (Q24187132) (← links)
- Interventions for fatigue in peripheral neuropathy (Q24187233) (← links)
- Management of Charcot-Marie-Tooth disease: improving long-term care with a multidisciplinary approach (Q26768401) (← links)
- The genetics of Charcot-Marie-Tooth disease: current trends and future implications for diagnosis and management (Q26777319) (← links)
- Charcot-Marie-Tooth disease and intracellular traffic (Q26824841) (← links)
- Regulation of the Epigenome by Vitamin C (Q27000867) (← links)
- Guidance in social and ethical issues related to clinical, diagnostic care and novel therapies for hereditary neuromuscular rare diseases: "translating" the translational (Q28485060) (← links)
- Haplotype-specific modulation of a SOX10/CREB response element at the Charcot-Marie-Tooth disease type 4C locus SH3TC2. (Q30009423) (← links)
- Psychometrics evaluation of Charcot-Marie-Tooth Neuropathy Score (CMTNSv2) second version, using Rasch analysis (Q30301300) (← links)
- Quality of life and measures of quality of life in patients with neuromuscular disorders (Q30455590) (← links)
- Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability (Q30513760) (← links)
- Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease (Q30543772) (← links)
- MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study. (Q31019878) (← links)
- Reproducibility, and age, body-weight and gender dependency of candidate skeletal muscle MRI outcome measures in healthy volunteers (Q33713240) (← links)
- Iron homeostasis in peripheral nervous system, still a black box? (Q33860305) (← links)
- The PMP22 gene and its related diseases (Q34316615) (← links)
- Proximal nerve magnetization transfer MRI relates to disability in Charcot-Marie-Tooth diseases (Q34465428) (← links)
- Quality-of-life in Charcot-Marie-Tooth disease: the patient's perspective (Q34621607) (← links)
- Axonal Charcot-Marie-Tooth disease patient-derived motor neurons demonstrate disease-specific phenotypes including abnormal electrophysiological properties. (Q34674307) (← links)
- Colony-stimulating factor-1 mediates macrophage-related neural damage in a model for Charcot-Marie-Tooth disease type 1X (Q35706394) (← links)
- CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis (Q35891892) (← links)
- Identification of drug modulators targeting gene-dosage disease CMT1A. (Q36106700) (← links)
- A Rasch Analysis of the Charcot-Marie-Tooth Neuropathy Score (CMTNS) in a Cohort of Charcot-Marie-Tooth Type 1A Patients (Q36251291) (← links)
- Plasma metabolome and skin proteins in Charcot-Marie-Tooth 1A patients (Q36390813) (← links)
- Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy (Q36698443) (← links)
- Vitamin C and Charcot-Marie-Tooth 1A: Pharmacokinetic considerations. (Q36701520) (← links)
- Anterior tibialis CMAP amplitude correlations with impairment in CMT1A. (Q36717951) (← links)
- Inherited peripheral neuropathies. (Q36822088) (← links)
- Changes of gait pattern in children with Charcot-Marie-Tooth disease type 1A: a 18 months follow-up study. (Q37000938) (← links)
- Transitioning outcome measures: relationship between the CMTPedS and CMTNSv2 in children, adolescents, and young adults with Charcot-Marie-Tooth disease (Q37021766) (← links)
- Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing (Q37078644) (← links)
- High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial (Q37118241) (← links)
- Metabolite profile of a mouse model of Charcot-Marie-Tooth type 2D neuropathy: implications for disease mechanisms and interventions (Q37120323) (← links)
- Distal Symmetric Polyneuropathy: A Review. (Q37444601) (← links)
- Outcome measures for Charcot-Marie-Tooth disease: clinical and neurofunctional assessment in children (Q37565640) (← links)
- Inherited neuropathies: clinical overview and update. (Q37571617) (← links)
- PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies (Q37715520) (← links)
- Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease (Q38007033) (← links)
- Neural and molecular features on Charcot-Marie-Tooth disease plasticity and therapy (Q38022624) (← links)
- A review of genetic counseling for Charcot Marie Tooth disease (CMT). (Q38100659) (← links)
- Clinical implications of genetic advances in Charcot-Marie-Tooth disease (Q38135690) (← links)
- Charcot-Marie-Tooth disease and pathways to molecular based therapies (Q38201741) (← links)
- Therapeutic options in Charcot-Marie-Tooth diseases (Q38363677) (← links)
- A Review of X-linked Charcot-Marie-Tooth Disease (Q38589445) (← links)
- Intensive strength and balance training with the Kinect console (Xbox 360) in a patient with CMT1A. (Q38649618) (← links)
- Nine-hole Peg Test and Ten-meter Walk Test for Evaluating Functional Loss in Chinese Charcot-Marie-Tooth Disease (Q38658209) (← links)
- A Computational Approach to Identify a Potential Alternative Drug With Its Positive Impact Toward PMP22. (Q38735331) (← links)
- Promoting peripheral myelin repair (Q38808666) (← links)
- Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease. (Q38979315) (← links)